These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
    Author: Watts SW, Thompson JM.
    Journal: J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222.
    Abstract:
    Our goal was to characterize the 5-hydroxytryptamine (5-HT) receptor(s) mediating contraction in the isolated right renal artery, testing the hypothesis that the 5-HT(2A) receptor would be the primary and likely only 5-HT receptor involved in contraction. Contraction of arteries was investigated in isolated tissue baths, and expression of 5-HT receptors was measured using immunohistochemical and Western analyses. Compared with endothelium-denuded rat aorta, a tissue with an established 5-HT(2A) receptor, endothelium-denuded renal artery contracted to 5-HT with a 10-fold greater potency. Surprisingly, the 5-HT(2B) receptor agonist alpha-methyl-5-(2-thienylmethoxy)-1H-indole-3-ethanamine hydrochloride (BW723C86) caused a concentration-dependent contraction that was antagonized by the 5-HT(2B) receptor antagonist 6-methyl-1,2,3,4-tetrahydro-1-[3,4-dimethoxyphenyl) methyl-9H-pyrido[3,4b]indole] hydrochloride (LY272015) and nonselective 5-HT(2) receptor antagonist 6-methyl-1-(1-methylethyl)-ergoline-8b-carboxylic acid 2-hydroxy-1-methylpropyl ester maleate (LY53857). Correlation of -log EC(50) values with binding affinities (pK(i)) indicated that contraction of the renal artery elicited by 13 different agonists was likely consistent with activation of a 5-HT(2A) (r = 0.928) and 5-HT(2B) (r = 0.843) receptor. 5-HT-induced contraction was shifted by the 5-HT(2A) receptor antagonist ketanserin (3 and 10 nM) and the 5-HT(2B) receptor antagonist LY272015 (10 and 50 nM). Higher than expected concentrations of the 5-HT(2A)/5-HT(2B) receptor antagonist LY53857 were needed to antagonize 5-HT-induced contraction and the 5-HT(2B) receptor antagonist 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine (RS127445) was virtually inactive. Western and immunohistochemical analyses of the renal artery validated the presence of 5-HT(2A) and 5-HT(2B) receptor protein. These results suggest that the renal artery possesses a complex 5-HT receptor population, including ketanserin- and LY272015-sensitive receptors. This unique pharmacology may reflect differences in 5-HT receptor coupling between tissues or heterogeneity in the subtype(s) of 5-HT receptors expressed in the renal artery.
    [Abstract] [Full Text] [Related] [New Search]